1 | MARK1, MARK2, MARK3, MARK4
|
| Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
|
| Gu GJ, Lund H, Wu D, Blokzijl A, Classon C, von Euler G, Landegren U, Sunnemark D, Kamali-Moghaddam M.
|
| Neuromolecular Med 15(3):458-69. doi: 10.1007/s12017-013-8232-3. Epub 2013 May 12.
2013
|
2 | MARK3, MITF, TFE3
|
| C-TAK1 interacts with microphthalmia-associated transcription factor, Mitf, but not the related family member Tfe3.
|
| Schwarz T, Murphy S, Sohn C, Mansky KC.
|
| Biochem Biophys Res Commun 394(4):890-5. Epub 2010 Mar 7.PMID: 20214879 2010
|
3 | MARK3
|
| High expression stability of microtubule affinity regulating kinase 3 (MARK3) makes it a reliable reference gene.
|
| Chia CY, Lim CW, Leong WT, Ling MH.
|
| IUBMB Life 62(3):200-3.PMID: 20087965 2010
|
4 | MARK2, MARK3
|
| Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.
|
| Lennerz JK, Hurov JB, White LS, Lewandowski KT, Prior JL, Planer GJ, Gereau RW 4th, Piwnica-Worms D, Schmidt RE, Piwnica-Worms H.
|
| Mol Cell Biol 30(21):5043-56. Epub 2010 Aug 23.
2010
|
5 | MARK1, MARK2, MARK3, MARK4
|
| Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein.
|
| Timm T, Marx A, Panneerselvam S, Mandelkow E, Mandelkow EM.
|
| BMC Neurosci 9 Suppl 2:S9. doi: 10.1186/1471-2202-9-S2-S9. Review.
2008
|
6 | MARK3
|
| Conformational instability of the MARK3 UBA domain compromises ubiquitin recognition and promotes interaction with the adjacent kinase domain.
|
| Murphy JM, Korzhnev DM, Ceccarelli DF, Briant DJ, Zarrine-Afsar A, Sicheri F, Kay LE, Pawson T.
|
| Proc Natl Acad Sci U S A 104(36):14336-41. Epub 2007 Aug 28.PMID: 17726107 2007
|
7 | MARK2, MARK3
|
| New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases.
|
| Dequiedt F, Martin M, Von Blume J, Vertommen D, Lecomte E, Mari N, Heinen MF, Bachmann M, Twizere JC, Huang MC, Rider MH, Piwnica-Worms H, Seufferlein T, Kettmann R.
|
| Mol Cell Biol 26(19):7086-102.PMID: 16980613 2006
|
8 | MARK1, MARK2, MARK3, MARK4
|
| Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation.
|
| Göransson O, Deak M, Wullschleger S, Morrice NA, Prescott AR, Alessi DR.
|
| J Cell Sci 119(Pt 19):4059-70. Epub 2006 Sep 12.PMID: 16968750 2006
|
9 | MARK3
|
| The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint.
|
| Bachmann M, Hennemann H, Xing PX, Hoffmann I, Möröy T.
|
| J Biol Chem 279(46):48319-28. Epub 2004 Aug 19.PMID: 15319445 2004
|
10 | MARK3, STK11
|
| Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1.
|
| Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D.
|
| Oncogene 22(30):4752-6. 2003
|
11 | MARK3
|
| MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.
|
| Drewes G, et al.
|
| Cell 89 : 297-308. 1997
|
12 | MARK3
|
| Assignment of MARK3 alias KP78 to human chromosome band 14q32.3 by in situ hybridization.
|
| Ono T, Kawabe T, Sonta S, Okamoto T.
|
| Cytogenet Cell Genet 79(1-2):101-2. 1997
|